In patients with ALCL, the BIM is encoded by BCL2L11, which is suppressed due to the recruitment of the SIN3a–HDAC1/2 corepressor complex, and treatment with the deacetylase inhibitor trichostatin This reverses this suppression and enhances tumor cell apoptosis [44]. Here, BCL2L11 is linked to neoplasm.